Surrogate markers aid lung cancer trials
Research suggests that surrogate markers for overall survival are acceptable endpoints for clinical trials of chemotherapy and radiotherapy in patients with lung cancer.
Source: MedWire News - Respiratory - Category: Respiratory Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Lung Cancer | Respiratory Medicine